Inbiomotion has published the results of a Phase III study looking at its MAFTest to personalized approaches to the disease. Inbiomotion, based in Barcelona’s¬†biotech hub, works on a highly selective biomarker for breast cancer. A Phase III study demonstrated that …

This awesome article Personalized Breast Cancer Treatment Coming Soon with Help from Spanish Biotech appeared first on Labiotech.eu. Be kind and don’t copy it without asking ūüėČ



Source link

Read More